ArticleResearch square2024

Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial.

Mehmet A Bilen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.